AAAAAA

   
Results: 1-13 |
Results: 13
More collaboration needed between drug development and imaging communities
Authors: Mankoff, DA Link, JM Unadkat, J Eary, JF Krohn, KA
Citation: Da. Mankoff et al., More collaboration needed between drug development and imaging communities, DRUG DISC T, 6(10), 2001, pp. 514-515
Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy
Authors: Byrd, DR Dunnwald, LK Mankoff, DA Anderson, BO Moe, RE Yeung, RS Schubert, EK Eary, JF
Citation: Dr. Byrd et al., Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy, ANN SURG O, 8(3), 2001, pp. 234-240
(18)Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer
Authors: Eubank, WB Mankoff, DA Takasugi, J Vesselle, H Eary, JF Shanley, TJ Gralow, JR Charlop, A Ellis, GK Lindsley, KL Austin-Seymour, MM Funkhouser, CP Livingston, RB
Citation: Wb. Eubank et al., (18)Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer, J CL ONCOL, 19(15), 2001, pp. 3516-3523
PET imaging for planning cancer therapy
Authors: Eary, JF
Citation: Jf. Eary, PET imaging for planning cancer therapy, J NUCL MED, 42(5), 2001, pp. 770-771
Imaging cellular proliferation as a measure of response to therapy
Authors: Krohn, KA Mankoff, DA Eary, JF
Citation: Ka. Krohn et al., Imaging cellular proliferation as a measure of response to therapy, J CLIN PHAR, 2001, pp. 96S-103S
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma
Authors: Folpe, AL Lyles, RH Sprouse, JT Conrad, EU Eary, JF
Citation: Al. Folpe et al., (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma, CLIN CANC R, 6(4), 2000, pp. 1279-1287
Positron emission tomography: imaging tumor response
Authors: Eary, JF Krohn, KA
Citation: Jf. Eary et Ka. Krohn, Positron emission tomography: imaging tumor response, EUR J NUCL, 27(12), 2000, pp. 1737-1739
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
Authors: Nason, KS Anderson, BO Byrd, DR Dunnwald, LK Eary, JF Mankoff, DA Livingston, R Schmidt, RA Jewell, KD Yeung, RS Moe, RE
Citation: Ks. Nason et al., Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma, CANCER, 89(11), 2000, pp. 2187-2194
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
Authors: Press, OW Eary, JF Gooley, T Gopal, AK Liu, S Rajendran, JG Maloney, DG Petersdorf, S Bush, SA Durack, LD Martin, PJ Fisher, DR Wood, B Borrow, JW Porter, B Smith, JP Matthews, DC Appelbaum, FR Bernstein, ID
Citation: Ow. Press et al., A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas, BLOOD, 96(9), 2000, pp. 2934-2942
Kinetic analysis of 2-[C-11]Thymidine PET imaging studies: Validation studies
Authors: Mankoff, DA Shields, AF Link, JM Graham, MM Muzi, M Peterson, LM Eary, JF Krohn, KA
Citation: Da. Mankoff et al., Kinetic analysis of 2-[C-11]Thymidine PET imaging studies: Validation studies, J NUCL MED, 40(4), 1999, pp. 614-624
Nuclear medicine in cancer diagnosis
Authors: Eary, JF
Citation: Jf. Eary, Nuclear medicine in cancer diagnosis, LANCET, 354(9181), 1999, pp. 853-857
2-[C-11]thymidine imaging of malignant brain tumors
Authors: Eary, JF Mankoff, DA Spence, AM Berger, MS Olshen, A Link, JM O'Sullivan, F Krohn, KA
Citation: Jf. Eary et al., 2-[C-11]thymidine imaging of malignant brain tumors, CANCER RES, 59(3), 1999, pp. 615-621
Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome
Authors: Matthews, DC Appelbaum, FR Eary, JF Fisher, DR Durack, LD Hui, TE Martin, PJ Mitchell, D Press, OW Storb, R Bernstein, ID
Citation: Dc. Matthews et al., Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome, BLOOD, 94(4), 1999, pp. 1237-1247
Risultati: 1-13 |